Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

March 22, 2023

Study Completion Date

March 22, 2023

Conditions
Prostate AdenocarcinomaProstate CarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8
Interventions
PROCEDURE

Angiogram

Undergo angiogram

PROCEDURE

Catheterization

Undergo prostatic arterial catheterization

DRUG

Gallium Ga-labeled PSMA-11

Given IV and IA

PROCEDURE

Positron Emission Tomography

Undergo PET scan

Trial Locations (1)

94143

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

Radiological Society of North America

OTHER

lead

Ryan Kohlbrenner, MD

OTHER

NCT04976257 - Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion | Biotech Hunter | Biotech Hunter